None listed
Conditions
Interventions
Intervention1: Guduchi ghan vati: drug to be given in dose of 500mg BD with lukewarm water before meals for 30 days
Control Intervention1: Not applicable: not applicable
Sponsors
Central Council for Research in Ayurvedic Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Residents of the identified containment zones, marked by government of Himachal Pradesh for high risk of COVID 19 Willing to take study medication, Provides written informed consent prior to initiation of study Procedures.
Exclusion criteria
Exclusion criteria: Persons already treated with study drug during the last 30 days; Pregnant and lactating females and those who have a pregnancy plan. Participants with any immunosuppressive medication or in an immune Compromised state or hematological disease. Laboratory confirmed COVID-19 cases with or without symptoms. Known allergy to the medication used in this trial. Not willing to participate in the study. Any other criteria, as per the investigator would jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of COVID 19 positive cases as confirmed by hospital by standard investigation, real time polymerase chain reaction test among Ayurveda users.Timepoint: At baseline,1 week, 2 weeks, 3 weeks, 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Incidence of severe COVID 19 positive cases (admitted in hospital and requiring ventilation and/or multi-organ failure as reported by hospital) among Ayurveda users. 2) Incidence of mortality due to COVID 19 among Ayurveda users as compared to non-users. 3) Incidence of any other ailment like cough, fever, sore throat etc. (as per questionnaire annexed) during this study. 4) Change in appetite, bowel habit, sleep among the users Timepoint: 7th, 14th, 22nd and 30th day after first visit | — |
Countries
India
Contacts
Public ContactDr Kavita Vyas
Central Council for Research in Ayurvedic Sciences
Outcome results
None listed